Aethlon Medical effects 1-for-5 reverse stock split - AEMD News | RalliesAethlon Medical effects 1-for-5 reverse stock split
A
AEMD• Reverse split and trading details
- Aethlon Medical filed to execute a 1-for-5 reverse stock split, effective 10 a.m. ET July 31, 2026.
- Split-adjusted trading is expected to start Aug. 4, 2026 on Nasdaq under AEMD; new CUSIP 00808Y703.
- Authorized common shares drop to 20,000,000 from 100,000,000; outstanding shares expected to fall to about 649,914 from 3,249,569.
- Reverse split framed as part of a capital-markets plan, including dilution management and Nasdaq minimum bid-price compliance.
•
